These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 23707696

  • 21. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
    Uppalapati SR, Kingston JJ, Murali HS, Batra HV.
    Vaccine; 2014 May 23; 32(25):3075-81. PubMed ID: 24699467
    [Abstract] [Full Text] [Related]

  • 22. Expression and purification of functional Clostridium perfringens alpha and epsilon toxins in Escherichia coli.
    Zhao Y, Kang L, Gao S, Zhou Y, Su L, Xin W, Su Y, Wang J.
    Protein Expr Purif; 2011 Jun 23; 77(2):207-13. PubMed ID: 21300155
    [Abstract] [Full Text] [Related]

  • 23. A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.
    Nagahama M, Oda M, Kobayashi K, Ochi S, Takagishi T, Shibutani M, Sakurai J.
    Microbiol Immunol; 2013 May 23; 57(5):340-5. PubMed ID: 23668605
    [Abstract] [Full Text] [Related]

  • 24. A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models.
    Tian JH, Fuhrmann SR, Kluepfel-Stahl S, Carman RJ, Ellingsworth L, Flyer DC.
    Vaccine; 2012 Jun 13; 30(28):4249-58. PubMed ID: 22537987
    [Abstract] [Full Text] [Related]

  • 25. Expression and purification of Clostridium perfringens beta-toxin glutathione S-transferase fusion protein.
    Steinthorsdottir V, Fridriksdottir V, Gunnarsson E, Andrésson OS.
    FEMS Microbiol Lett; 1995 Aug 01; 130(2-3):273-8. PubMed ID: 7649450
    [Abstract] [Full Text] [Related]

  • 26. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
    Hauer PJ, Clough NE.
    Dev Biol Stand; 1999 Aug 01; 101():85-94. PubMed ID: 10566780
    [Abstract] [Full Text] [Related]

  • 27. [Induced expression of alpha-toxin gene of Clostridium perfringens in recombinant Lactobacillus casei and their immunoprotective in mice].
    Li X, Xia C, Li Y.
    Wei Sheng Wu Xue Bao; 2009 Aug 01; 49(8):1115-20. PubMed ID: 19835176
    [Abstract] [Full Text] [Related]

  • 28. Enhanced expression of recombinant beta toxin of Clostridium perfringens type B using a commercially available Escherichia coli strain.
    Bakhshi F, Pilehchian Langroudi R, Eimani BG.
    Onderstepoort J Vet Res; 2016 Jun 30; 83(1):a1136. PubMed ID: 27380656
    [Abstract] [Full Text] [Related]

  • 29. Recombinant unpurified rETXH106P/ CTB-rETXY196E protects rabbits against Clostridium perfringens epsilon toxin.
    Peng X, Li X, Peng G, Feng L, Jiang Y, Luo Y.
    J Vet Med Sci; 2021 Apr 03; 83(3):441-446. PubMed ID: 33551442
    [Abstract] [Full Text] [Related]

  • 30. Detection of beta2 and major toxin genes by PCR in Clostridium perfringens field isolates of domestic animals suffering from enteritis or enterotoxaemia.
    Sting R.
    Berl Munch Tierarztl Wochenschr; 2009 Apr 03; 122(9-10):341-7. PubMed ID: 19863004
    [Abstract] [Full Text] [Related]

  • 31. Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model.
    Fisher DJ, Fernandez-Miyakawa ME, Sayeed S, Poon R, Adams V, Rood JI, Uzal FA, McClane BA.
    Infect Immun; 2006 Sep 03; 74(9):5200-10. PubMed ID: 16926413
    [Abstract] [Full Text] [Related]

  • 32. Synthesis of peptide based epsilon toxin vaccine by covalent anchoring to tetanus toxoid.
    Kaushik H, Dixit A, Garg LC.
    Anaerobe; 2018 Oct 03; 53():50-55. PubMed ID: 29920342
    [Abstract] [Full Text] [Related]

  • 33. B-cell epitope of beta toxin of Clostridium perfringens genetically conjugated to a carrier protein: expression, purification and characterization of the chimeric protein.
    Bhatia B, Solanki AK, Kaushik H, Dixit A, Garg LC.
    Protein Expr Purif; 2014 Oct 03; 102():38-44. PubMed ID: 24996028
    [Abstract] [Full Text] [Related]

  • 34. Oral immunization of mice against Clostridium perfringens epsilon toxin with a Lactobacillus casei vector vaccine expressing epsilon toxoid.
    Alimolaei M, Golchin M, Daneshvar H.
    Infect Genet Evol; 2016 Jun 03; 40():282-287. PubMed ID: 27012151
    [Abstract] [Full Text] [Related]

  • 35. Production and evaluation of a monoclonal antibody to Clostridium perfringens type D epsilon toxin.
    El-Enbaawy MI, Abdalla YA, Hussein AZ, Osman RM, Selim SA.
    Egypt J Immunol; 2003 Jun 03; 10(1):77-81. PubMed ID: 15719625
    [Abstract] [Full Text] [Related]

  • 36. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
    Neeson BN, Clark GC, Atkins HS, Lingard B, Titball RW.
    Microb Pathog; 2007 Oct 03; 43(4):161-5. PubMed ID: 17604945
    [Abstract] [Full Text] [Related]

  • 37. Recombinant Alpha, Beta, and Epsilon Toxins of Clostridium perfringens: Production Strategies and Applications as Veterinary Vaccines.
    Ferreira MR, Moreira GM, Cunha CE, Mendonça M, Salvarani FM, Moreira ÂN, Conceição FR.
    Toxins (Basel); 2016 Nov 21; 8(11):. PubMed ID: 27879630
    [Abstract] [Full Text] [Related]

  • 38. Modified toxin-binding inhibition (ToBI) test for epsilon antitoxin determination in serum of immunized rabbits.
    Sobrinho EM, Cangussu AS, Brandi IV, Sari RS, Almeida AC, Colen F, Quintilio W, Santos HO.
    Vet Immunol Immunopathol; 2010 Nov 15; 138(1-2):129-33. PubMed ID: 20709411
    [Abstract] [Full Text] [Related]

  • 39. Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccines.
    Ebert E, Oppling V, Werner E, Cussler K.
    FEMS Immunol Med Microbiol; 1999 Jul 15; 24(3):299-311. PubMed ID: 10397315
    [Abstract] [Full Text] [Related]

  • 40. In silico design and in vitro analysis of a recombinant trivalent fusion protein candidate vaccine targeting virulence factor of Clostridium perfringens.
    Katalani C, Nematzadeh G, Ahmadian G, Amani J, Kiani G, Ehsani P.
    Int J Biol Macromol; 2020 Mar 01; 146():1015-1023. PubMed ID: 31726124
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.